查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1423838

全球宿主細胞污染物測試市場 - 全球產業分析、規模、份額、成長、趨勢、預測 (2031) - 按產品類型、按平台、按應用、按最終用戶、按地區

Host Cell Contaminant Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region:
出版日期: | 出版商: Fairfield Market Research | 英文 198 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

在生物製藥的動態模式中，宿主細胞污染物的識別和定量是確保新型療法的安全性和有效性的關鍵挑戰。 來自各種來源（包括酵母菌、大腸桿菌和哺乳動物細胞）的宿主細胞蛋白是具有不同特性、等電點和分子量的異質混合物。 隨著生物製藥產業不斷創新，對強大的宿主細胞污染物測試解決方案的需求不斷增加。

在宿主細胞污染物檢測領域的不同利益相關者中，生物製藥公司已成為領跑者，以其巨大的市場份額和在藥物開發和製造方面的豐富專業知識推動市場發展。Masu。 根據最近的市場分析，生物製藥公司在全球宿主細胞污染物檢測市場中佔有重要份額，預計這一趨勢在預測期內將持續下去。

擁有成熟生產能力、經濟實力和戰略市場基礎設施□□的大型生物製藥公司在新藥研發和市場開拓中發揮著至關重要的作用。 此外，這些公司經常與新興生物製藥公司合作，利用它們的資源籌集研究資金，擴大客戶群，並應對藥物開發和商業化的複雜局面。我正在克服它。

生物製藥公司認識到宿主細胞污染物測試對於確保產品品質和法規遵循至關重要，因此越來越多地投資於先進的測試方法。 這些公司旨在透過優先考慮抗體和小分子藥物等風險較低的後期產品來降低風險，同時加快藥物開發和商業化的步伐。

隨著生物製藥公司的崛起，合約研究組織 (CRO) 有望成為宿主細胞污染物檢測市場的強大競爭對手。 透過與領先製藥公司的策略聯盟和協議，CRO 利用其臨床前和臨床研究專業知識提供全面的檢測服務。

與稀釋現有投資者股權的傳統投資模式不同，CRO 正在探索替代融資途徑，並將自己定位為藥物開發生態系統中的重要合作夥伴。 透過進行臨床前評估、毒性測試和臨床試驗，CRO 在加速藥物開發過程、同時確保法規遵循和患者安全方面發揮關鍵作用。

同樣，合約製造組織 (CMO) 是生物製藥價值鏈不可或缺的一部分，提供針對特定製藥要求的專業製造能力。 透過與 CRO 和生物製藥公司密切合作，CMO 促進從藥物開發到商業生產的無縫過渡，確保整個產品生命週期的可擴展性和效率。

由於對新治療劑的不斷追求以及對品質保證和監管合規性的日益重視，全球宿主細胞污染物檢測市場預計未來將顯著擴大。 隨著生物製藥公司繼續推動創新並建立策略合作夥伴關係，對先進測試解決方案的需求預計將激增。

本報告調查了全球宿主細胞污染物測試市場，並提供了市場概述，以及按產品類型、平台、應用、最終用戶、區域和進入市場的競爭對手劃分的趨勢。我們提供了趨勢等。

目錄

第 1 章執行摘要

第二章市場概述

  • 市場定義與細分
  • 市場動態
  • 價值鏈分析
  • 波特五力分析
  • 新冠肺炎 (COVID-19) 影響分析
  • 烏克蘭和俄羅斯之間衝突的影響
  • 經濟概況
  • 杵分析

第 3 章 2018-2031 年全球宿主細胞污染物檢測市場前景

  • 2018-2031 年全球宿主細胞污染物測試市場前景（按產品類型、價值（十億美元））
  • 2018-2031 年全球宿主細胞污染物測試市場前景（按平台劃分）、價值（十億美元）
  • 2018-2031 年全球宿主細胞污染物測試市場前景（按應用、價值（十億美元））
  • 2018-2031 年全球宿主細胞污染物測試市場前景（按最終用戶劃分）價值（十億美元）
  • 2018-2031 年全球宿主細胞污染物測試市場前景（按地區、價值（十億美元））

第 4 章北美宿主細胞污染物測試市場前景，2018-2031

第 5 章歐洲宿主細胞污染物測試市場前景，2018-2031

第 6 章亞太地區宿主細胞污染物測試市場展望，2018-2031 年

第 7 章拉丁美洲宿主細胞污染物測試市場展望，2018-2031 年

第 8 章中東與非洲宿主細胞污染物檢測市場前景，2018-2031 年

第九章競爭態勢

  • 產品類型與平台熱圖
  • 製造商和平台熱圖
  • 2023 年公司市佔率分析
  • 競爭力儀表板
  • 公司簡介
    • BioGenes GmbH
    • Bio-Rad Laboratories, Inc.
    • Cisbio Bioassays
    • Cygnus Technologies LLC
    • Enzo Life Sciences, Inc.
    • ForteBio
    • GE Healthcare Life Sciences
    • Molecular Devices LLC
    • ProteinSimple
    • Thermo Fisher Scientific, Inc.

第 10 章附錄

簡介目錄

In the dynamic landscape of biopharmaceuticals, the identification and quantification of host cell contaminants stand as pivotal tasks in ensuring the safety and efficacy of novel therapeutics. Host cell proteins, originating from diverse sources such as yeast, E. coli, and mammalian cells, present a heterogeneous mix with varying properties, isoelectric points, and molecular masses. As the biopharmaceutical industry continues to innovate, the demand for robust host cell contaminant testing solutions is on the rise.

Bio-Pharmaceutical Companies Spearhead Market Growth

Among the diverse stakeholders in the host cell contaminant testing arena, bio-pharmaceutical companies emerge as frontrunners, driving market expansion with their substantial market share and extensive expertise in drug development and manufacturing. Recent market analysis indicates that bio-pharmaceutical companies commanded a significant share in the global host cell contaminant testing market, a trend projected to persist in the forecast period.

With their established production capabilities, economic prowess, and strategic market infrastructure, bio-pharmaceutical giants play a pivotal role in shepherding novel drugs from development to market introduction. Moreover, these companies often engage in partnerships and collaborations with emerging biopharmaceutical entities, leveraging their resources to finance research, expand customer bases, and navigate the complex landscape of drug development and commercialization.

Recognizing the critical importance of host cell contaminant testing in ensuring product quality and regulatory compliance, bio-pharmaceutical companies are increasingly investing in advanced testing methodologies. By prioritizing low-risk, late-stage products such as antibodies and small molecule drugs, these companies aim to mitigate risks while accelerating the pace of drug development and commercialization.

Rising Role of Contract Research Organizations (CROs)

In tandem with the ascendancy of bio-pharmaceutical companies, contract research organizations (CROs) are poised to emerge as formidable contenders in the host cell contaminant testing market. Through strategic partnerships and agreements with leading pharmaceutical entities, CROs are leveraging their expertise in preclinical and clinical research to offer comprehensive testing services.

Unlike traditional investment models that dilute existing investor stakes, CROs are exploring alternative financing avenues, positioning themselves as indispensable partners in the drug development ecosystem. By conducting preclinical evaluations, toxicology studies, and clinical trials, CROs play a vital role in expediting the drug development process while ensuring regulatory compliance and patient safety.

Similarly, contract manufacturing organizations (CMOs) are integral players in the biopharmaceutical value chain, offering specialized manufacturing capabilities tailored to specific drug requirements. By collaborating closely with CROs and bio-pharmaceutical companies, CMOs facilitate seamless transitions from drug development to commercial production, ensuring scalability and efficiency throughout the product lifecycle.

Market Outlook and Future Prospects

Looking ahead, the global host cell contaminant testing market is poised for significant expansion, driven by the relentless pursuit of novel therapeutics and the increasing emphasis on quality assurance and regulatory compliance. As bio-pharmaceutical companies continue to drive innovation and forge strategic partnerships, the demand for advanced testing solutions is expected to surge.

Moreover, the growing role of CROs and CMOs in the biopharmaceutical ecosystem underscores the importance of collaborative approaches in drug development and manufacturing. By harnessing collective expertise and resources, stakeholders across the industry are poised to accelerate the pace of innovation and bring life-saving treatments to patients worldwide.

Competitive Analysis

Key companies functioning in the global host cell contaminant testing market including:

  • BioGenes GmbH
  • Bio-Rad Laboratories, Inc.
  • Cisbio Bioassays
  • Cygnus Technologies LLC (A Maravai Lifesciences Company)
  • Enzo Life Sciences, Inc.
  • ForteBio (A Pall Company)
  • GE Healthcare Life Sciences
  • Molecular Devices LLC
  • ProteinSimple (A BioTechne Brand)
  • Thermo Fisher Scientific, Inc.
  • Others

Market Segmentation

Product Type

  • PCR-based Assays
  • ELISA-based Assays

Platform

  • Microbial
  • Mammalian
  • Others

Application

  • Research & Development
  • Clinical Applications

End User

  • Biopharmaceutical Companies
  • Contract Research Organizations
  • Contract Manufacturing Organizations
  • Academic & Research Institutes

Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Host Cell Contaminant Testing Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Host Cell Contaminant Testing Market Outlook, 2018 - 2031

  • 3.1. Global Host Cell Contaminant Testing Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
    • 3.1.1. Key Highlights
      • 3.1.1.1. PCR-based Assays
      • 3.1.1.2. ELISA-based Assays
  • 3.2. Global Host Cell Contaminant Testing Market Outlook, by Platform, Value (US$ Bn), 2018 - 2031
    • 3.2.1. Key Highlights
      • 3.2.1.1. Microbial
      • 3.2.1.2. Mammalian
      • 3.2.1.3. Others
  • 3.3. Global Host Cell Contaminant Testing Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
    • 3.3.1. Key Highlights
      • 3.3.1.1. Research & Development
      • 3.3.1.2. Clinical Applications
  • 3.4. Global Host Cell Contaminant Testing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 3.4.1. Key Highlights
      • 3.4.1.1. Biopharmaceutical Companies
      • 3.4.1.2. Contract Research Organizations
      • 3.4.1.3. Contract Manufacturing Organizations
      • 3.4.1.4. Academic & Research Institutes
  • 3.5. Global Host Cell Contaminant Testing Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
    • 3.5.1. Key Highlights
      • 3.5.1.1. North America
      • 3.5.1.2. Europe
      • 3.5.1.3. Asia Pacific
      • 3.5.1.4. Latin America
      • 3.5.1.5. Middle East & Africa

4. North America Host Cell Contaminant Testing Market Outlook, 2018 - 2031

  • 4.1. North America Host Cell Contaminant Testing Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. PCR-based Assays
      • 4.1.1.2. ELISA-based Assays
  • 4.2. North America Host Cell Contaminant Testing Market Outlook, by Platform, Value (US$ Bn), 2018 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. Microbial
      • 4.2.1.2. Mammalian
      • 4.2.1.3. Others
  • 4.3. North America Host Cell Contaminant Testing Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. Research & Development
      • 4.3.1.2. Clinical Applications
  • 4.4. North America Host Cell Contaminant Testing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 4.4.1. Key Highlights
      • 4.4.1.1. Biopharmaceutical Companies
      • 4.4.1.2. Contract Research Organizations
      • 4.4.1.3. Contract Manufacturing Organizations
      • 4.4.1.4. Academic & Research Institutes
  • 4.5. North America Host Cell Contaminant Testing Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 4.5.1. Key Highlights
      • 4.5.1.1. U.S. Host Cell Contaminant Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 4.5.1.2. U.S. Host Cell Contaminant Testing Market by Platform, Value (US$ Bn), 2018 - 2031
      • 4.5.1.3. U.S. Host Cell Contaminant Testing Market by Application, Value (US$ Bn), 2018 - 2031
      • 4.5.1.4. U.S. Host Cell Contaminant Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 4.5.1.5. Canada Host Cell Contaminant Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 4.5.1.6. Canada Host Cell Contaminant Testing Market by Platform, Value (US$ Bn), 2018 - 2031
      • 4.5.1.7. Canada Host Cell Contaminant Testing Market by Application, Value (US$ Bn), 2018 - 2031
      • 4.5.1.8. Canada Host Cell Contaminant Testing Market by End User, Value (US$ Bn), 2018 - 2031
    • 4.5.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Host Cell Contaminant Testing Market Outlook, 2018 - 2031

  • 5.1. Europe Host Cell Contaminant Testing Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. PCR-based Assays
      • 5.1.1.2. ELISA-based Assays
  • 5.2. Europe Host Cell Contaminant Testing Market Outlook, by Platform, Value (US$ Bn), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Microbial
      • 5.2.1.2. Mammalian
      • 5.2.1.3. Others
  • 5.3. Europe Host Cell Contaminant Testing Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Research & Development
      • 5.3.1.2. Clinical Applications
  • 5.4. Europe Host Cell Contaminant Testing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 5.4.1. Key Highlights
      • 5.4.1.1. Biopharmaceutical Companies
      • 5.4.1.2. Contract Research Organizations
      • 5.4.1.3. Contract Manufacturing Organizations
      • 5.4.1.4. Academic & Research Institutes
  • 5.5. Europe Host Cell Contaminant Testing Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 5.5.1. Key Highlights
      • 5.5.1.1. Germany Host Cell Contaminant Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.5.1.2. Germany Host Cell Contaminant Testing Market by Platform, Value (US$ Bn), 2018 - 2031
      • 5.5.1.3. Germany Host Cell Contaminant Testing Market by Application, Value (US$ Bn), 2018 - 2031
      • 5.5.1.4. Germany Host Cell Contaminant Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 5.5.1.5. U.K. Host Cell Contaminant Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.5.1.6. U.K. Host Cell Contaminant Testing Market by Platform, Value (US$ Bn), 2018 - 2031
      • 5.5.1.7. U.K. Host Cell Contaminant Testing Market by Application, Value (US$ Bn), 2018 - 2031
      • 5.5.1.8. U.K. Host Cell Contaminant Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 5.5.1.9. France Host Cell Contaminant Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.5.1.10. France Host Cell Contaminant Testing Market by Platform, Value (US$ Bn), 2018 - 2031
      • 5.5.1.11. France Host Cell Contaminant Testing Market by Application, Value (US$ Bn), 2018 - 2031
      • 5.5.1.12. France Host Cell Contaminant Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 5.5.1.13. Italy Host Cell Contaminant Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.5.1.14. Italy Host Cell Contaminant Testing Market by Platform, Value (US$ Bn), 2018 - 2031
      • 5.5.1.15. Italy Host Cell Contaminant Testing Market by Application, Value (US$ Bn), 2018 - 2031
      • 5.5.1.16. Italy Host Cell Contaminant Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 5.5.1.17. Turkey Host Cell Contaminant Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.5.1.18. Turkey Host Cell Contaminant Testing Market by Platform, Value (US$ Bn), 2018 - 2031
      • 5.5.1.19. Turkey Host Cell Contaminant Testing Market by Application, Value (US$ Bn), 2018 - 2031
      • 5.5.1.20. Turkey Host Cell Contaminant Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 5.5.1.21. Russia Host Cell Contaminant Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.5.1.22. Russia Host Cell Contaminant Testing Market by Platform, Value (US$ Bn), 2018 - 2031
      • 5.5.1.23. Russia Host Cell Contaminant Testing Market by Application, Value (US$ Bn), 2018 - 2031
      • 5.5.1.24. Russia Host Cell Contaminant Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 5.5.1.25. Rest of Europe Host Cell Contaminant Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.5.1.26. Rest of Europe Host Cell Contaminant Testing Market by Platform, Value (US$ Bn), 2018 - 2031
      • 5.5.1.27. Rest of Europe Host Cell Contaminant Testing Market by Application, Value (US$ Bn), 2018 - 2031
      • 5.5.1.28. Rest of Europe Host Cell Contaminant Testing Market by End User, Value (US$ Bn), 2018 - 2031
    • 5.5.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Host Cell Contaminant Testing Market Outlook, 2018 - 2031

  • 6.1. Asia Pacific Host Cell Contaminant Testing Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. PCR-based Assays
      • 6.1.1.2. ELISA-based Assays
  • 6.2. Asia Pacific Host Cell Contaminant Testing Market Outlook, by Platform, Value (US$ Bn), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Microbial
      • 6.2.1.2. Mammalian
      • 6.2.1.3. Others
  • 6.3. Asia Pacific Host Cell Contaminant Testing Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. Research & Development
      • 6.3.1.2. Clinical Applications
  • 6.4. Asia Pacific Host Cell Contaminant Testing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 6.4.1. Key Highlights
      • 6.4.1.1. Biopharmaceutical Companies
      • 6.4.1.2. Contract Research Organizations
      • 6.4.1.3. Contract Manufacturing Organizations
      • 6.4.1.4. Academic & Research Institutes
  • 6.5. Asia Pacific Host Cell Contaminant Testing Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 6.5.1. Key Highlights
      • 6.5.1.1. China Host Cell Contaminant Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 6.5.1.2. China Host Cell Contaminant Testing Market by Platform, Value (US$ Bn), 2018 - 2031
      • 6.5.1.3. China Host Cell Contaminant Testing Market by Application, Value (US$ Bn), 2018 - 2031
      • 6.5.1.4. China Host Cell Contaminant Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 6.5.1.5. Japan Host Cell Contaminant Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 6.5.1.6. Japan Host Cell Contaminant Testing Market by Platform, Value (US$ Bn), 2018 - 2031
      • 6.5.1.7. Japan Host Cell Contaminant Testing Market by Application, Value (US$ Bn), 2018 - 2031
      • 6.5.1.8. Japan Host Cell Contaminant Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 6.5.1.9. South Korea Host Cell Contaminant Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 6.5.1.10. South Korea Host Cell Contaminant Testing Market by Platform, Value (US$ Bn), 2018 - 2031
      • 6.5.1.11. South Korea Host Cell Contaminant Testing Market by Application, Value (US$ Bn), 2018 - 2031
      • 6.5.1.12. South Korea Host Cell Contaminant Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 6.5.1.13. India Host Cell Contaminant Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 6.5.1.14. India Host Cell Contaminant Testing Market by Platform, Value (US$ Bn), 2018 - 2031
      • 6.5.1.15. India Host Cell Contaminant Testing Market by Application, Value (US$ Bn), 2018 - 2031
      • 6.5.1.16. India Host Cell Contaminant Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 6.5.1.17. Southeast Asia Host Cell Contaminant Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 6.5.1.18. Southeast Asia Host Cell Contaminant Testing Market by Platform, Value (US$ Bn), 2018 - 2031
      • 6.5.1.19. Southeast Asia Host Cell Contaminant Testing Market by Application, Value (US$ Bn), 2018 - 2031
      • 6.5.1.20. Southeast Asia Host Cell Contaminant Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 6.5.1.21. Rest of Asia Pacific Host Cell Contaminant Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 6.5.1.22. Rest of Asia Pacific Host Cell Contaminant Testing Market by Platform, Value (US$ Bn), 2018 - 2031
      • 6.5.1.23. Rest of Asia Pacific Host Cell Contaminant Testing Market by Application, Value (US$ Bn), 2018 - 2031
      • 6.5.1.24. Rest of Asia Pacific Host Cell Contaminant Testing Market by End User, Value (US$ Bn), 2018 - 2031
    • 6.5.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Host Cell Contaminant Testing Market Outlook, 2018 - 2031

  • 7.1. Latin America Host Cell Contaminant Testing Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. PCR-based Assays
      • 7.1.1.2. ELISA-based Assays
  • 7.2. Latin America Host Cell Contaminant Testing Market Outlook, by Platform, Value (US$ Bn), 2018 - 2031
    • 7.2.1. Key Highlights
      • 7.2.1.1. Microbial
      • 7.2.1.2. Mammalian
      • 7.2.1.3. Others
  • 7.3. Latin America Host Cell Contaminant Testing Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Research & Development
      • 7.3.1.2. Clinical Applications
  • 7.4. Latin America Host Cell Contaminant Testing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 7.4.1. Key Highlights
      • 7.4.1.1. Biopharmaceutical Companies
      • 7.4.1.2. Contract Research Organizations
      • 7.4.1.3. Contract Manufacturing Organizations
      • 7.4.1.4. Academic & Research Institutes
  • 7.5. Latin America Host Cell Contaminant Testing Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 7.5.1. Key Highlights
      • 7.5.1.1. Brazil Host Cell Contaminant Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 7.5.1.2. Brazil Host Cell Contaminant Testing Market by Platform, Value (US$ Bn), 2018 - 2031
      • 7.5.1.3. Brazil Host Cell Contaminant Testing Market by Application, Value (US$ Bn), 2018 - 2031
      • 7.5.1.4. Brazil Host Cell Contaminant Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 7.5.1.5. Mexico Host Cell Contaminant Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 7.5.1.6. Mexico Host Cell Contaminant Testing Market by Platform, Value (US$ Bn), 2018 - 2031
      • 7.5.1.7. Mexico Host Cell Contaminant Testing Market by Application, Value (US$ Bn), 2018 - 2031
      • 7.5.1.8. Mexico Host Cell Contaminant Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 7.5.1.9. Argentina Host Cell Contaminant Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 7.5.1.10. Argentina Host Cell Contaminant Testing Market by Platform, Value (US$ Bn), 2018 - 2031
      • 7.5.1.11. Argentina Host Cell Contaminant Testing Market by Application, Value (US$ Bn), 2018 - 2031
      • 7.5.1.12. Argentina Host Cell Contaminant Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 7.5.1.13. Rest of Latin America Host Cell Contaminant Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 7.5.1.14. Rest of Latin America Host Cell Contaminant Testing Market by Platform, Value (US$ Bn), 2018 - 2031
      • 7.5.1.15. Rest of Latin America Host Cell Contaminant Testing Market by Application, Value (US$ Bn), 2018 - 2031
      • 7.5.1.16. Rest of Latin America Host Cell Contaminant Testing Market by End User, Value (US$ Bn), 2018 - 2031
    • 7.5.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Host Cell Contaminant Testing Market Outlook, 2018 - 2031

  • 8.1. Middle East & Africa Host Cell Contaminant Testing Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. PCR-based Assays
      • 8.1.1.2. ELISA-based Assays
  • 8.2. Middle East & Africa Host Cell Contaminant Testing Market Outlook, by Platform, Value (US$ Bn), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Microbial
      • 8.2.1.2. Mammalian
      • 8.2.1.3. Others
  • 8.3. Middle East & Africa Host Cell Contaminant Testing Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. Research & Development
      • 8.3.1.2. Clinical Applications
  • 8.4. Middle East & Africa Host Cell Contaminant Testing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 8.4.1. Key Highlights
      • 8.4.1.1. Biopharmaceutical Companies
      • 8.4.1.2. Contract Research Organizations
      • 8.4.1.3. Contract Manufacturing Organizations
      • 8.4.1.4. Academic & Research Institutes
  • 8.5. Middle East & Africa Host Cell Contaminant Testing Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 8.5.1. Key Highlights
      • 8.5.1.1. GCC Host Cell Contaminant Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 8.5.1.2. GCC Host Cell Contaminant Testing Market by Platform, Value (US$ Bn), 2018 - 2031
      • 8.5.1.3. GCC Host Cell Contaminant Testing Market by Application, Value (US$ Bn), 2018 - 2031
      • 8.5.1.4. GCC Host Cell Contaminant Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 8.5.1.5. South Africa Host Cell Contaminant Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 8.5.1.6. South Africa Host Cell Contaminant Testing Market by Platform, Value (US$ Bn), 2018 - 2031
      • 8.5.1.7. South Africa Host Cell Contaminant Testing Market by Application, Value (US$ Bn), 2018 - 2031
      • 8.5.1.8. South Africa Host Cell Contaminant Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 8.5.1.9. Egypt Host Cell Contaminant Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 8.5.1.10. Egypt Host Cell Contaminant Testing Market by Platform, Value (US$ Bn), 2018 - 2031
      • 8.5.1.11. Egypt Host Cell Contaminant Testing Market by Application, Value (US$ Bn), 2018 - 2031
      • 8.5.1.12. Egypt Host Cell Contaminant Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 8.5.1.13. Nigeria Host Cell Contaminant Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 8.5.1.14. Nigeria Host Cell Contaminant Testing Market by Platform, Value (US$ Bn), 2018 - 2031
      • 8.5.1.15. Nigeria Host Cell Contaminant Testing Market by Application, Value (US$ Bn), 2018 - 2031
      • 8.5.1.16. Nigeria Host Cell Contaminant Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 8.5.1.17. Rest of Middle East & Africa Host Cell Contaminant Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 8.5.1.18. Rest of Middle East & Africa Host Cell Contaminant Testing Market by Platform, Value (US$ Bn), 2018 - 2031
      • 8.5.1.19. Rest of Middle East & Africa Host Cell Contaminant Testing Market by Application, Value (US$ Bn), 2018 - 2031
      • 8.5.1.20. Rest of Middle East & Africa Host Cell Contaminant Testing Market by End User, Value (US$ Bn), 2018 - 2031
    • 8.5.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Product Type vs Platform Heatmap
  • 9.2. Manufacturer vs Platform Heatmap
  • 9.3. Company Market Share Analysis, 2023
  • 9.4. Competitive Dashboard
  • 9.5. Company Profiles
    • 9.5.1. BioGenes GmbH
      • 9.5.1.1. Company Overview
      • 9.5.1.2. Product Type Portfolio
      • 9.5.1.3. Financial Overview
      • 9.5.1.4. Business Strategies and Development
    • 9.5.2. Bio-Rad Laboratories, Inc.
      • 9.5.2.1. Company Overview
      • 9.5.2.2. Product Type Portfolio
      • 9.5.2.3. Financial Overview
      • 9.5.2.4. Business Strategies and Development
    • 9.5.3. Cisbio Bioassays
      • 9.5.3.1. Company Overview
      • 9.5.3.2. Product Type Portfolio
      • 9.5.3.3. Financial Overview
      • 9.5.3.4. Business Strategies and Development
    • 9.5.4. Cygnus Technologies LLC
      • 9.5.4.1. Company Overview
      • 9.5.4.2. Product Type Portfolio
      • 9.5.4.3. Financial Overview
      • 9.5.4.4. Business Strategies and Development
    • 9.5.5. Enzo Life Sciences, Inc.
      • 9.5.5.1. Company Overview
      • 9.5.5.2. Product Type Portfolio
      • 9.5.5.3. Financial Overview
      • 9.5.5.4. Business Strategies and Development
    • 9.5.6. ForteBio
      • 9.5.6.1. Company Overview
      • 9.5.6.2. Product Type Portfolio
      • 9.5.6.3. Financial Overview
      • 9.5.6.4. Business Strategies and Development
    • 9.5.7. GE Healthcare Life Sciences
      • 9.5.7.1. Company Overview
      • 9.5.7.2. Product Type Portfolio
      • 9.5.7.3. Financial Overview
      • 9.5.7.4. Business Strategies and Development
    • 9.5.8. Molecular Devices LLC
      • 9.5.8.1. Company Overview
      • 9.5.8.2. Product Type Portfolio
      • 9.5.8.3. Financial Overview
      • 9.5.8.4. Business Strategies and Development
    • 9.5.9. ProteinSimple
      • 9.5.9.1. Company Overview
      • 9.5.9.2. Product Type Portfolio
      • 9.5.9.3. Financial Overview
      • 9.5.9.4. Business Strategies and Development
    • 9.5.10. Thermo Fisher Scientific, Inc.
      • 9.5.10.1. Company Overview
      • 9.5.10.2. Product Type Portfolio
      • 9.5.10.3. Financial Overview
      • 9.5.10.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations